KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Profit After Tax (2018 - 2025)

Historic Profit After Tax for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.5 million.

  • Twist Bioscience's Profit After Tax rose 345.89% to -$30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.6 million, marking a year-over-year increase of 6117.95%. This contributed to the annual value of -$77.7 million for FY2025, which is 6277.42% up from last year.
  • Per Twist Bioscience's latest filing, its Profit After Tax stood at -$30.5 million for Q4 2025, which was up 345.89% from -$27.2 million recorded in Q3 2025.
  • Twist Bioscience's 5-year Profit After Tax high stood at $20.4 million for Q2 2025, and its period low was -$85.6 million during Q2 2024.
  • Moreover, its 5-year median value for Profit After Tax was -$42.4 million (2022), whereas its average is -$42.9 million.
  • As far as peak fluctuations go, Twist Bioscience's Profit After Tax tumbled by 6959.45% in 2021, and later surged by 12383.18% in 2025.
  • Twist Bioscience's Profit After Tax (Quarter) stood at -$45.6 million in 2021, then grew by 8.21% to -$41.8 million in 2022, then dropped by 2.83% to -$43.0 million in 2023, then increased by 26.53% to -$31.6 million in 2024, then rose by 3.46% to -$30.5 million in 2025.
  • Its last three reported values are -$30.5 million in Q4 2025, -$27.2 million for Q3 2025, and $20.4 million during Q2 2025.